A synthesized peptide derived from human c-Rel c-Rel contains an amino-terminal DNA-binding domain referred to as the REL homology domain (REH) and carboxy-terminal transactivation domains. The c-Rel protein is typically inhibited in unstimulated cells by I Kappa B Alpha and I Kappa B Beta . c-Rel expression is highest in hematopoietic cells with extensive research studies demonstrating its role in immune cell function and pathogenesis of disease.
Alternative Names:
C Rel, Proto oncogene c Rel, REL
Boster Bio Anti-c-Rel Monoclonal Antibody catalog M01880. Tested in WB, IP applications. This antibody reacts with Human.
